دورية أكاديمية
أعرض في EDS

Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia.

التفاصيل البيبلوغرافية
العنوان: Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia.
المؤلفون: Koide K; Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan., Yao S; Centre for Diagnostics and Vaccine Development, Centres for Disease Control, Taipei, Taiwan., Chiang CS; Centre for Diagnostics and Vaccine Development, Centres for Disease Control, Taipei, Taiwan., Thuy PTB; Department of Molecular Biology for Infectious Disease, Vietnam National Children's Hospital, Hanoi, Vietnam., Nga DTT; Division of General Internal Medicine, Centre for Tropical Diseases, Vietnam National Children's Hospital, Hanoi, Vietnam., Huong DT; Division of General Internal Medicine, Centre for Tropical Diseases, Vietnam National Children's Hospital, Hanoi, Vietnam., Dien TM; Surgical Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam., Vichit O; National Immunization Program, Ministry of Health, Cambodia., Vutthikol Y; National Immunization Program, Ministry of Health, Cambodia., Sovannara S; National Immunization Program, Ministry of Health, Cambodia., Samnang C; Vaccine-Preventable Diseases and Immunization, World Health Organization, Cambodia., Takayama I; Research Centre for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan., Ainai A; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Nakajima N; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan., Otsuka N; Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan., Kamachi K; Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: kamachi@nih.go.jp., Saitoh A; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
المصدر: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2022 Dec; Vol. 31, pp. 263-269. Date of Electronic Publication: 2022 Oct 18.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer Country of Publication: Netherlands NLM ID: 101622459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-7173 (Electronic) Linking ISSN: 22137165 NLM ISO Abbreviation: J Glob Antimicrob Resist Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Published by Elsevier Ltd. on behalf of International Society of Chemotherapy for Infection and Cancer
مواضيع طبية MeSH: Bordetella pertussis*/genetics , Whooping Cough*/epidemiology, Humans ; Macrolides/pharmacology ; Anti-Bacterial Agents/pharmacology ; Genotype ; Drug Resistance, Bacterial ; Mutation ; Asia, Southeastern ; Asia, Eastern
مستخلص: Objectives: Macrolide-resistant Bordetella pertussis (MRBP) has been emerging and prevailing in mainland China since 2011. In this study, we aimed to investigate the genotype and macrolide resistance of circulating B. pertussis in East and Southeast Asia using genetic analyses.
Methods: A total of 302 DNA extracts from clinical specimens and isolates from 2010 to 2020 were analyzed: 145 from Vietnam, 76 from Cambodia, 48 from Taiwan, and 33 from Japan. Genotypes were determined by multilocus variable-number tandem-repeat analysis (MLVA). Macrolide-resistant A2047G mutation in B. pertussis 23S rRNA was investigated using the duplex Cycleave real-time polymerase chain reaction (PCR) assay. Whole-genome sequencing was performed on two MRBP isolates that were identified for the first time in Taiwan.
Results: Overall, 286 DNA extracts (95%) generated a complete MLVA genotype and 283 DNA extracts (94%) yielded a complete result for the A2047G mutation analysis. The A2047G mutation was detected in 18 DNA extracts: fourteen from Vietnam, one from Cambodia, two from Taiwan, and one from Japan. Most of them (78%) showed the genotypes MT104 and MT195, which have previously been reported in Chinese MRBP isolates. Further, the Taiwanese MRBP isolates were classified into the MT104 clade of Chinese MRBP isolates.
Conclusion: After MRBP emerged and spread in mainland China, it may have spread to East and Southeast Asia in the 2010s. Continued surveillance targeting the A2047G mutation of MRBP is needed to prevent further spread of this emerging pathogen.
(Copyright © 2022. Published by Elsevier Ltd.)
References: Lancet Reg Health West Pac. 2021 Feb 05;8:100098. (PMID: 34327426)
Pediatrics. 2015 Feb;135(2):331-43. (PMID: 25560446)
Emerg Infect Dis. 2019 Dec;25(12):2205-2214. (PMID: 31742507)
Int J Infect Dis. 2015 Jun;35:24-6. (PMID: 25861926)
Antimicrob Agents Chemother. 2013 Oct;57(10):5193-4. (PMID: 23877687)
PLoS One. 2015 Sep 25;10(9):e0138941. (PMID: 26406905)
BMC Pharmacol Toxicol. 2014 Feb 20;15:6. (PMID: 24555709)
PLoS One. 2012;7(2):e31985. (PMID: 22348138)
J Int Med Res. 2022 Feb;50(2):3000605221078782. (PMID: 35225710)
Pediatr Infect Dis J. 2018 Jun;37(6):e145-e148. (PMID: 29088029)
Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1211-4. (PMID: 27146879)
Expert Rev Vaccines. 2020 Nov;19(11):1093-1099. (PMID: 33034224)
Pediatr Infect Dis J. 2021 Feb 1;40(2):87-90. (PMID: 33021592)
Clin Microbiol Infect. 2014 Nov;20(11):O825-30. (PMID: 24816168)
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549. (PMID: 29722887)
J Med Microbiol. 2012 Dec;61(Pt 12):1662-1668. (PMID: 22918864)
Pediatr Infect Dis J. 2019 Apr;38(4):370-376. (PMID: 30882726)
Emerg Infect Dis. 2017 Apr;23(4):699-701. (PMID: 28322702)
Front Microbiol. 2022 Jul 18;13:901617. (PMID: 35923401)
J Med Microbiol. 2008 Dec;57(Pt 12):1577-1580. (PMID: 19018032)
J Clin Microbiol. 2015 Nov;53(11):3418-22. (PMID: 26224847)
Emerg Microbes Infect. 2019;8(1):461-470. (PMID: 30898080)
Pediatr Infect Dis J. 2005 May;24(5 Suppl):S58-61. (PMID: 15876927)
Int J Infect Dis. 2017 Sep;62:56-58. (PMID: 28751008)
PLoS One. 2014 Aug 11;9(8):e104984. (PMID: 25110940)
Emerg Infect Dis. 2020 Oct;26(10):2511-2513. (PMID: 32946738)
Clin Microbiol Infect. 2013 Jun;19(6):E260-2. (PMID: 23480481)
Jpn J Infect Dis. 2020 Sep 24;73(5):361-362. (PMID: 32350216)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
فهرسة مساهمة: Keywords: 23S rRNA; Bordetella pertussis; East and Southeast Asia; Macrolide-resistant A2047G mutation; Multilocus variable-number tandem-repeat analysis; Whole-genome sequencing
المشرفين على المادة: 0 (Macrolides)
0 (Anti-Bacterial Agents)
تواريخ الأحداث: Date Created: 20221021 Date Completed: 20221220 Latest Revision: 20221229
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9750937
DOI: 10.1016/j.jgar.2022.10.007
PMID: 36270447
قاعدة البيانات: MEDLINE
الوصف
تدمد:2213-7173
DOI:10.1016/j.jgar.2022.10.007